Windstone Capital Partners Facilitates $25.4 Million Investment in Fallbrook Technologies Inc.
Posted on: Wednesday, 14 January 2009, 14:21 CST
- Helping commercialize revolutionary NuVinci(R) transmission; major transportation and cleantech applications -
Windstone provided advisory support for the investment. NGEN III, LP (NGEN) and Robeco, the investment arm of
The investment will enable Fallbrook to continue the commercialization of its NuVinci continuously variable planetary (CVP) transmission, and to accelerate the development of advanced technologies. A number of applications of NuVinci technology - both current and projected - represent significant clean technology opportunities.
"Windstone played a critical role in securing our investment," said
Windstone provides a wide range of financial advisory services to a number of corporate clients, including private, micro-cap and small-cap companies. Windstone's goal is to provide these companies the same comprehensive services normally available to larger corporations and public companies.
"In terms of changing markets, I consider this to be the most significant deal in the history of our company," said
This is Fallbrook's first venture financed round; previous financing for the company was done through private equity investment.
NuVinci technology is the most practical, economical and universally adaptable continuously variable transmission for human- and motor-powered vehicles and machines. The NuVinci CVP uses a set of rotating and tilting balls positioned between the input and output components of a transmission. Tilting the balls changes their contact diameters and varies the speed ratio. The NuVinci CVP can be used in virtually any transmission-based vehicle or device - from bicycles and outdoor power equipment to cars, trucks and wind turbines.
About Windstone
Windstone Capital Partners, Inc. is a specialized Financial Advisory and Merchant Banking Firm, providing the highest level of institutional financing, merger, acquisition and divestiture for small to medium-sized private and public companies, as well as selected middle market, closely-held businesses. Windstone's financial advisory services help tap into a worldwide network of talent and resources necessary to develop a company's vision, strengthen its strategic plan, access talent, pull strings, sew-up financing and pave each step of the way to success.
To learn more about Windstone, please visit www.windstonecapital.com.
About Fallbrook Technologies Inc.
Fallbrook Technologies Inc. (Fallbrook) is a technology company dedicated to improving the performance and flexibility of transmissions for vehicles and equipment. Fallbrook's revolutionary NuVinci(R) continuously variable planetary (CVP) technology is applicable to virtually any machines that use a transmission such as bicycles, light electric vehicles, automobiles, agricultural equipment, and wind turbines, among others. NuVinci technology offers companies the flexibility to design and produce next-generation products that are better tailored to their unique business, market and competitive requirements.
Fallbrook has built an extensive portfolio of over 300 patents and patent applications worldwide. Fallbrook's vigorous research and development activities will continue to enhance the performance and capabilities of NuVinci technology.
To learn more about Fallbrook and its NuVinci technology, please visit www.fallbrooktech.com.
SOURCE Windstone Capital Partners
Source: PR Newswire
Related Articles
- WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board
- BorgWarner to Supply DualTronic(R) Transmission Control System for Fiat Powertrain Technologies' First Dry Dual-Clutch Transmission
- ISTO Technologies to Present at OneMedPlace Emerging Company Finance Conference
- FolioDynamix Acquires SunGard Advisory Technologies
- DermTech Adds Australian Thought Leader Dr. Scott Menzies, Director of the Sydney Melanoma Diagnostic Centre, to Company's Melanoma Advisory Board
- Texas Emerging Technology Fund Invests $750,000 in StarVision Technologies, Inc.
- MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Company's Scientific Advisory Board
- DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., As a Member of the Company's Scientific Advisory Board
- Genesis Bioventures Announces Dr. John Todd To Chair The Company's Clinical Advisory Board
- CytoCore Announces Dr. Steven Waggoner Joins Company's Medical Advisory Board
User Comments (0)

RSS Feeds